1,4-dihydropyridine has been researched along with Neuralgia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berger, ND; Bladen, C; Gadotti, VM; Gündüz, MG; Şafak, C; Şimşek, R; Zamponi, GW | 1 |
| Bladen, C; Chen, L; Gadotti, VM; Gündüz, MG; Şafak, C; Şimşek, R; Zamponi, GW; Zhang, FX | 1 |
2 other study(ies) available for 1,4-dihydropyridine and Neuralgia
| Article | Year |
|---|---|
1,4-Dihydropyridine derivatives with T-type calcium channel blocking activity attenuate inflammatory and neuropathic pain.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Cell Line; Dihydropyridines; Humans; Inflammation; Ion Channel Gating; Mice; Mice, Inbred C57BL; Neuralgia; Small Molecule Libraries | 2015 |
Analgesic effect of a broad-spectrum dihydropyridine inhibitor of voltage-gated calcium channels.
Topics: Analgesics; Animals; Calcium Channel Blockers; Calcium Channels; Cell Line; Dihydropyridines; Humans; Neuralgia; Rats | 2015 |